Epigenomics
Epigenomics provides molecular diagnostic test for the early detection of colorectal cancer.
Business Model:
Revenue: $410.9k
Employees: 11-50
Rankings
Industries / Tags:
Detailed Epigenomics Information
Epigenomics was acquired by
Cathay Fortune Corp..
The acquisition happend on 2017-04-27.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Geneststrabe 5
City: Berlin
State: berlin
Zip: 10829
Country: DE
Financial Info
Stage:
grant
Raised Last:
$3M
Raised Total:$106M
Social
Metrics
4,182,734Website Global Rank
2,492Website Monthly Traffic
Twitter Followers
Description
Epigenomics provides molecular diagnostic test for the early detection of colorectal cancer.
Contact Phone:
Contact Email:
Epigenomics went public on 7/21/2004 on the FRA
Listed Exchange:
FRA
IPO Date:
7/21/2004
Ticker Symbol:
EPGNY
Amount Raised:
$51M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
